BOOST Pharma: Valuation, Funding & Investors
A clinical-stage biopharmaceutical company advancing BT-101, a novel mesenchymal stem cell therapy for infants born with osteogenesis imperfecta, a condition characterized by fragile bones, frequent fractures, and bone deformity.
Leadership & Board
- Current Number of Employees
- 18
- Current LinkedIn Followers
- 2,018
Latest Estimated Valuation
- Total Amount Raised
- $49M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $34M
- Latest Funding Round
- Investment
Employee Trend
BOOST Pharma had 18 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
BOOST Pharma had 2,018 followers as of November 2, 2026. The number of followers increased by 7 (0.35%) week-over-week.
2,018Latest Followers Count
7(0.35%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 03, 2025 | Investment | $34.00M | ― |
| Oct 28, 2025 | Convertible Notes | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Industrifonden | Investment |
| Sound Bioventures | Investment |
| Karolinska Development | Investment |
| Industrifonden | Convertible Notes |
| Karolinska Development | Convertible Notes |
Similar Companies
A snapshot of private companies similar to BOOST Pharma, helping you discover and navigate related company profiles.
